Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2023

Nov 21, 2023

30071_dirs_2023-11-21_57cc52b8-2339-4a96-9eae-534ad71e8c67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16

Reporting Person: Burt Carol (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-16 ResMed Common Stock A 1768 Acquired 2890 Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 14051 Indirect

Footnotes

F1: Amended to reflect change in holdings between direct and indirect for shares transferred.